Search Results

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of AMG 386 with Paclitaxel and Carboplatin as First-Line Treatment of Subjetcs with FIGO Stage III-IV Epithelial Ovarian, Primary Peritoneal or Fallopian Tube Cancers

Disease Types: Gynecology
Available at: Kerrville,  Metropolitan,  Northeast,  Stone Oak

A Phase 3, Multicenter, Randomized, Double-Blind, Active-Controlled Study of the Safety and Efficacy of Rolapitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Subjects Receiving Moderately Emetogenic Chemotherapy (MED)

Disease Types: Supportive Care
Available at: Kerrville,  Medical Center,  Metropolitan,  New Braunfels,  Northeast,  Stone Oak

Decision Impact Analysis of Foundation Medicine's Comprehensive Cancer Genomic Test in Advanced Solid Tumors

Disease Types: Developmental Therapeutics
Available at: Kerrville,  Metropolitan,  Northeast,  Stone Oak

An Open-label, Multicenter, Randomized, Phase 2 Study of a Recombinant Human Anti-VEGFR-2 Monoclonal Antibody, IMC-1121B in Combination with Platinum-based Chemotherapy versus Platinum-based Chemotherapy Alone as First-line Treatment of Patients with Recurrent or Advanced Non-Small Cell Lung Cancer (NSCLC)

Disease Types: Lung
Available at: Kerrville,  Metropolitan,  Northeast,  Stone Oak

A Phase 3 Open-Label, Randomized, Multicenter Study of NKTR-102 versus Treatment of Physician's Choice (TPC) in Patients with Locally Recurrent or Metastatic Breast Cancer Previously Treated with an Antrhacycline, a Taxane, and Capecitabine

Disease Types: Breast
Available at: Kerrville,  Metropolitan,  Northeast,  Stone Oak

A Randomized, Phase II Trial of Preoperative MM-121 with Paclitaxel in HER2-negative Breast Cancer

Disease Types: Breast
Available at: Kerrville,  Metropolitan,  Northeast,  Stone Oak

An Open-Label, Multicenter, Randomized, Phase 2 Study Evaluating the Efficacy and Safety of Ramucirumab Drug Product (IMC-1121B) in Combination with Eribulin Versus Eribulin Monotherapy in Unresectable, Locally-Recurrent or Metastatic Breast Cancer Patients Previously Treated with Anthracycline and Taxane Therapy

Disease Types: Breast
Available at: Metropolitan,  Northeast,  Stone Oak

A Phase I/Randomized Phase 2 Study to Evaluate LY2603618 in Combination with Gemcitabine in Patients with Pancreatic Cancer

Disease Types: Pancreatic
Available at: Metropolitan,  Northeast,  Stone Oak

A Phase III, Randomized Study to Assess the Efficacy and Safety of Perifosine Added to the Combination of Bortezomib and Dexamethasone in Multiple Myeloma Patients Previously Treated with Bortezomib

Disease Types: Multiple Myeloma
Available at: Kerrville,  Medical Center,  Metropolitan,  New Braunfels,  Northeast,  Stone Oak

Studying Interventions for Managing Patients with Chronic Myeloid Leukemia in Chronic Phase: The 5-Year Prospective Cohort Study

Disease Types: Leukemia (CLL, CML)
Available at: Kerrville,  Northeast,  Stone Oak

A Phase II, Multicenter, Single-Arm, Feasibility Study of Eribulin in Combination with Capecitabine for Adjuvant Treatment in Estrogen Receptor-Postive Early Stage Breast Cancer

Disease Types: Breast
Available at: Kerrville,  Metropolitan,  Northeast,  Stone Oak

An Open-Label, Randomized, Multi-Center Phase III Study to Compare the Safety and Efficacy of TK1258 Versus Sorafenib in Patients with Metastastic Renal Cell Carcinoma After Failure of Anti-Angiogenic (VEGF-targeted and mTOR inhibitor therapies)

Disease Types: Renal Cell
Available at: Kerrville,  Northeast,  Stone Oak

A Open-Label, Randomized, Phase 2 Study to Assess the Effectiveness of RCHOP With or Without VELCADE in Previously Untreated Patients with Non-Germinal Center B-Cell-like Diffuse Large B-Cell Lymphoma

Disease Types: Lymphoma
Available at: Kerrville,  Metropolitan,  Northeast,  Stone Oak

A Phase III Clinical Trial Comparing Trastuzumab Given Concurrently with Radiation and Radiation Alone for Women with HER2-Positive Ductal Carcinoma In Situ Resected by Lumpectomy

Disease Types: Breast
Available at: Kerrville,  Northeast,  Stone Oak

A Phase III Trial Evaluating the Addition of Cetuximab to Paclitaxel, Cisplatin, and Radiation for Patients with Esophageal Cancer Who are Treated Without Surgery

Disease Types: Head and Neck
Available at: Northeast

A Phase III Clinical Trial Comparing Trastuzumab Given Concurrently with Radiation and Radiation Alone for Women with HER2-Positive Ductal Carcinoma In Situ Resected by Lumpectomy

Disease Types:
Available at: Northeast

A Randomized, Phase III Study of Conventional Whole Breast Irradiation (WBI) Versus Partial Breast Irradiation (PBI) for Women with Stage 0, I, or II Breast Cancer

Disease Types: Breast
Available at: Northeast

Radiation Therapy Clinical Trial: A Phase III Study of Postoperative Radiation Therapy (IMRT) +/- Cetuximab for Locally-Advanced Resected Head and Neck Cancer

Disease Types: Head and Neck
Available at: Northeast

A Randomized, Double-Blind, Phase 3 Study of Docetaxel and Ramucirumab versus Docetaxel and Placebo in the Treatment of Stage IV Non-Small Cell Lung Cancer Following Disease Progression after One Prior Platinum-Based Therapy

Disease Types: Lung
Available at: Kerrville,  Medical Center,  New Braunfels,  Northeast,  Southeast,  Stone Oak

A Randomized, Double Blind, Multicenter Phase 3 Study of Irinotecan, Folinic Acid, and 5-Fluorouracil Plus Ramucirumab or Placebo in Patients with Metastatic Colorectal Carcinoma Progressive During or Following First-Line Combination Therapy with Bevacizumab, Oxaliplatin, and a Fluoropyrimidine

Disease Types: Colorectal
Available at: Kerrville,  Medical Center,  Metropolitan,  New Braunfels,  Northeast,  Stone Oak

A Phase 2, Multicenter, Single-Arm Study of Eribulin Mesylate with Trastuzumab as First-Line Therapy for Locally Recurrent or Metastatic Human Epidermal Growth Factor Receptor Two (HER2) Positive Breast Cancer

Disease Types: Breast
Available at: Kerrville,  Northeast,  Stone Oak

Randomized, Double-Blind, Placebo Controlled, Multi-Center Phase 3 Study of Denosumab as Adjuvant Treatment for Women with Early Stage Breast Cancer at HIgh Risk of Recurrence

Disease Types: Breast
Available at: Kerrville,  Metropolitan,  Northeast,  Stone Oak

A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Deferasirox in Patients with Myelodysplastic Syndromes (low/int-1 Risk) and Transfusional Iron Overload

Disease Types: Myelodysplasia
Available at: Kerrville,  Medical Center,  New Braunfels,  Northeast,  Stone Oak

Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Long-Term Safety and Efficacy of Darbepoetin Alfa Administered at 500 ig Once-Every-3-Weeks to a Hemoglobiin Ceiling of 12.0 g/dl in Anemic Subjects with Advanced Stage Non-Small Cell Lung Cancer Receiving Multi-Cycle Chemotherapy

Disease Types: Lung
Available at: Kerrville,  Medical Center,  New Braunfels,  Northeast,  Stone Oak

A Randomized, Phase III, Double-Blind, Placebo-Controlled Multicenter Trial of Daily Everolimus in Combination with Trastuzumab and Vinorelbine, in Pretreated Women with HER2/neu Over-Expressing Locally Advanced or Metastatic Breast Cancer

Disease Types: Breast
Available at: Kerrville,  Metropolitan,  Northeast,  Stone Oak